Your browser doesn't support javascript.
loading
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?
Stock, Carmel J; Conti, Caterina; Montero-Fernandez, Ángeles; Caramori, Gaetano; Molyneaux, Philip L; George, Peter M; Kokosi, Maria; Kouranos, Vaslis; Maher, Toby M; Chua, Felix; Rice, Alexandra; Denton, Christopher P; Nicholson, Andrew G; Wells, Athol; Sestini, Piersante; Renzoni, Elisabetta A.
Afiliación
  • Stock CJ; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK c.stock@imperial.ac.uk.
  • Conti C; Respiratory Unit ASST, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Montero-Fernandez Á; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Caramori G; UOC di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy.
  • Molyneaux PL; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • George PM; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Kokosi M; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Kouranos V; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Maher TM; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Chua F; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Rice A; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Denton CP; Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, London, UK.
  • Nicholson AG; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Wells A; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
  • Sestini P; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Toscana, Italy.
  • Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust/ National Heart and Lung Institute, Imperial College, London, UK.
Thorax ; 75(10): 901-903, 2020 10.
Article en En | MEDLINE | ID: mdl-32580994
ABSTRACT
The MUC5B promoter variant rs35705950 is associated with idiopathic pulmonary fibrosis (IPF). MUC5B glycoprotein is overexpressed in IPF lungs. We examined immunohistochemical expression of MUC5B in different interstitial lung disease patterns according to rs35705950 T-allele carriage. We observed increased expression of MUC5B in T-allele carriers in both distal airways and honeycomb cysts in patients with IPF (n=23), but no difference in MUC5B expression according to T-carrier status in the distal airways of patients with idiopathic non-specific interstitial pneumonitis (n=17), in scleroderma-associated non-specific interstitial pneumonitis (n=15) or in control lungs (n=20), suggesting that tissue overexpression in MUC5B rs35705950 T-carriers is specific to IPF.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedades Pulmonares Intersticiales / Fibrosis Pulmonar Idiopática / Mucina 5B Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Thorax Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedades Pulmonares Intersticiales / Fibrosis Pulmonar Idiopática / Mucina 5B Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Thorax Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido